{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:35:17Z","timestamp":1787020517190,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s12913-014-0676-0","type":"journal-article","created":{"date-parts":[[2014,12,23]],"date-time":"2014-12-23T11:53:31Z","timestamp":1419335611000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["The economic burden of pulmonary arterial hypertension (PAH) in the US on payers and patients"],"prefix":"10.1186","volume":"14","author":[{"given":"Mirko","family":"Sikirica","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serban R","family":"Iorga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Bancroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Potash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,24]]},"reference":[{"key":"676_CR1","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","volume":"30","author":"N Gali\u00e8","year":"2009","unstructured":"Gali\u00e8 N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G, ESC Committee for Practice Guidelines (CPG): Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J. 2009, 30: 2493-2537. 10.1093\/eurheartj\/ehp297.","journal-title":"Eur Heart J"},{"key":"676_CR2","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1183\/09031936.00056110","volume":"37","author":"RJ Barst","year":"2011","unstructured":"Barst RJ, Ertel SI, Beghetti M, Ivy DD: Pulmonary arterial hypertension: a comparison between children and adults. Eur Respir J. 2011, 37: 665-677. 10.1183\/09031936.00056110.","journal-title":"Eur Respir J"},{"key":"676_CR3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1183\/09059180.00007309","volume":"19","author":"M Humbert","year":"2010","unstructured":"Humbert M: Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology. Eur Respir Rev. 2010, 19: 59-63. 10.1183\/09059180.00007309.","journal-title":"Eur Respir Rev"},{"key":"676_CR4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.4065\/84.2.191","volume":"84","author":"MD McGoon","year":"2009","unstructured":"McGoon MD, Kane GC: Pulmonary hypertension: diagnosis and management. Mayo Clin Proc. 2009, 84: 191-207. 10.4065\/84.2.191.","journal-title":"Mayo Clin Proc"},{"key":"676_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1086\/316947","volume":"68","author":"RD Machado","year":"2001","unstructured":"Machado RD, Pauciulo MW, Thomson JR, Lane KB, Morgan NV, Wheeler L, Phillips JA, Newman J, Williams D, Gali\u00e8 N, Manes A, McNeil K, Yacoub M, Mikhail G, Rogers P, Corris P, Humbert M, Donnai D, Martensson G, Tranebjaerg L, Loyd JE, Trembath RC, Nichols WC: BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension. Am J Hum Genet. 2001, 68: 92-102. 10.1086\/316947.","journal-title":"Am J Hum Genet"},{"key":"676_CR6","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1136\/jmg.40.12.865","volume":"40","author":"RE Harrison","year":"2003","unstructured":"Harrison RE, Flanagan JA, Sankelo M, Abdalla SA, Rowell J, Machado RD, Elliott CG, Robbins IM, Olschewski H, McLaughlin V, Gruenig E, Kermeen F, Halme M, R\u00e4is\u00e4nen-Sokolowski A, Laitinen T, Morrell NW, Trembath RC: Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia. J Med Genet. 2003, 40: 865-871. 10.1136\/jmg.40.12.865.","journal-title":"J Med Genet"},{"issue":"60","key":"676_CR7","first-page":"419","volume":"2011","author":"N Nakanishi","year":"2009","unstructured":"Nakanishi N, European Society of Cardiology, European Respiratory Society: ESC\/ERS pulmonary hypertension guidelines and connective tissue disease. Allergol Int. 2009, 2011 (60): 419-424.","journal-title":"Allergol Int"},{"key":"676_CR8","doi-asserted-by":"publisher","first-page":"W471","DOI":"10.2214\/AJR.10.5417","volume":"197","author":"IC Tsai","year":"2011","unstructured":"Tsai IC, Tsai WL, Wang KY, Chen MC, Liang KW, Tsai HY, Liao WC: Comprehensive MDCT evaluation of patients with pulmonary hypertension: diagnosing underlying causes with the updated Dana Point 2008 classification. AJR Am J Roentgenol. 2011, 197: W471-W481. 10.2214\/AJR.10.5417.","journal-title":"AJR Am J Roentgenol"},{"key":"676_CR9","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1378\/chest.09-1140","volume":"137","author":"DB Badesch","year":"2010","unstructured":"Badesch DB, Raskob GE, Elliott CG, Krichman AM, Farber HW, Frost AE, Barst RJ, Benza RL, Liou TG, Turner M, Giles S, Feldkircher K, Miller DP, McGoon MD: Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest. 2010, 137: 376-387. 10.1378\/chest.09-1140.","journal-title":"Chest"},{"key":"676_CR10","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1161\/CIRCULATIONAHA.109.911818","volume":"122","author":"M Humbert","year":"2010","unstructured":"Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Ya\u00efci A, Weitzenblum E, Cordier JF, Chabot F, Dromer C, Pison C, Reynaud-Gaubert M, Haloun A, Laurent M, Hachulla E, Cottin V, Degano B, Ja\u00efs X, Montani D, Souza R, Simonneau G: Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation. 2010, 122: 156-163. 10.1161\/CIRCULATIONAHA.109.911818.","journal-title":"Circulation"},{"key":"676_CR11","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1183\/09059180.00006411","volume":"20","author":"VV McLaughlin","year":"2011","unstructured":"McLaughlin VV: Looking to the future: a new decade of pulmonary arterial hypertension therapy. Eur Respir Rev. 2011, 20: 262-269. 10.1183\/09059180.00006411.","journal-title":"Eur Respir Rev"},{"key":"676_CR12","doi-asserted-by":"publisher","first-page":"521","DOI":"10.7326\/0003-4819-149-8-200810210-00004","volume":"149","author":"G Simonneau","year":"2008","unstructured":"Simonneau G, Rubin LJ, Gali\u00e8 N, Barst RJ, Fleming TR, Frost AE, Engel PJ, Kramer MR, Burgess G, Collings L, Cossons N, Sitbon O, Badesch DB, PACES Study Group: Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial. Ann Intern Med. 2008, 149: 521-530. 10.7326\/0003-4819-149-8-200810210-00004.","journal-title":"Ann Intern Med"},{"key":"676_CR13","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1164\/rccm.200603-358OC","volume":"174","author":"VV McLaughlin","year":"2006","unstructured":"McLaughlin VV, Oudiz RJ, Frost A, Tapson VF, Murali S, Channick RN, Badesch DB, Barst RJ, Hsu HH, Rubin LJ: Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2006, 174: 1257-1263. 10.1164\/rccm.200603-358OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"676_CR14","first-page":"1","volume":"54","author":"A Hyduk","year":"2005","unstructured":"Hyduk A, Croft JB, Ayala C, Zheng K, Zheng ZJ, Mensah GA: Pulmonary hypertension surveillance\u2013United States, 1980\u20132002. MMWR Surveill Summ. 2005, 54: 1-28.","journal-title":"MMWR Surveill Summ"},{"key":"676_CR15","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1185\/03007995.2011.604310","volume":"27","author":"NY Kirson","year":"2011","unstructured":"Kirson NY, Birnbaum HG, Ivanova JI, Waldman T, Joish V, Williamson T: Prevalence of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in the United States. Curr Med Res Opin. 2011, 27: 1763-1768. 10.1185\/03007995.2011.604310.","journal-title":"Curr Med Res Opin"},{"key":"676_CR16","doi-asserted-by":"publisher","first-page":"947","DOI":"10.3111\/13696998.2012.690801","volume":"15","author":"R Copher","year":"2012","unstructured":"Copher R, Cerulli A, Watkins A, Laura Monsalvo M: Treatment patterns and healthcare system burden of managed care patients with suspected pulmonary arterial hypertension in the United States. J Med Econ. 2012, 15: 947-955. 10.3111\/13696998.2012.690801.","journal-title":"J Med Econ"},{"key":"676_CR17","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3111\/13696998.2010.496694","volume":"13","author":"M Angalakuditi","year":"2010","unstructured":"Angalakuditi M, Edgell E, Beardsworth A, Buysman E, Bancroft T: Treatment patterns and resource utilization and costs among patients with pulmonary arterial hypertension in the United States. J Med Econ. 2010, 13: 393-402. 10.3111\/13696998.2010.496694.","journal-title":"J Med Econ"},{"key":"676_CR18","doi-asserted-by":"publisher","first-page":"500","DOI":"10.3111\/13696998.2012.665109","volume":"15","author":"Q Said","year":"2012","unstructured":"Said Q, Martin BC, Joish VN, Kreilick C, Mathai SC: The cost to managed care of managing pulmonary hypertension. J Med Econ. 2012, 15: 500-508. 10.3111\/13696998.2012.665109.","journal-title":"J Med Econ"},{"key":"676_CR19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2165\/11592430-000000000-00000","volume":"9","author":"NY Kirson","year":"2011","unstructured":"Kirson NY, Birnbaum HG, Ivanova JI, Waldman T, Joish V, Williamson T: Excess costs associated with patients with pulmonary arterial hypertension in a US privately insured population. Appl Health Econ Health Policy. 2011, 9: 293-303. 10.2165\/11592430-000000000-00000.","journal-title":"Appl Health Econ Health Policy"},{"key":"676_CR20","unstructured":"Health Insurance Portability and Accountability Act of 1996 [http:\/\/www.cms.gov\/Regulations-and-Guidance\/HIPAA-Administrative-Simplification\/HIPAAGenInfo\/TheHIPAALawandRelated-Information.html]"},{"key":"676_CR21","unstructured":"U.S. Department of Health & Human Services [http:\/\/answers.hhs.gov\/ohrp\/categories\/1566]"},{"key":"676_CR22","unstructured":"Comorbidity Software Healthcare Cost and Utilization Project (HCUP) [http:\/\/www.hcup-us.ahrq.gov\/toolssoftware\/comorbidity\/comorbidity.jsp]"},{"key":"676_CR23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1471-2466-12-75","volume":"12","author":"A Berger","year":"2012","unstructured":"Berger A, Edelsberg J, Teal S, Mychaskiw MA, Oster G: Changes in healthcare utilization and costs associated with sildenafil therapy for pulmonary arterial hypertension: a retrospective cohort study. BMC Pulm Med. 2012, 12: 75-10.1186\/1471-2466-12-75.","journal-title":"BMC Pulm Med"},{"key":"676_CR24","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.rmed.2010.01.002","volume":"104","author":"H Wilkens","year":"2010","unstructured":"Wilkens H, Grimminger F, Hoeper M, St\u00e4hler G, Ehlken B, Plesnila-Frank C, Berger K, Resch A, Ghofrani A: Burden of pulmonary arterial hypertension in Germany. Respir Med. 2010, 104: 902-910. 10.1016\/j.rmed.2010.01.002.","journal-title":"Respir Med"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12913-014-0676-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-014-0676-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-014-0676-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-014-0676-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T03:05:15Z","timestamp":1630551915000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-014-0676-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["676"],"URL":"https:\/\/doi.org\/10.1186\/s12913-014-0676-0","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"3 September 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"676"}}